Article and Video CATEGORIES

Cancer Journey

Search By

One Patient's Plea on "Giving Tuesday"
Author
linnea

Giving Tuesday Health Logo

I have lived with lung cancer since 2005. On this "Giving Tuesday," I ask that you join me in making an end-of-year donation to an organization that truly deserves it, the Global Resource for Advancing Cancer Education (GRACE).

GRACE has had a great year of growth. It conducted three in-person patient forums this year: the ALK+ Patient Forum, the Acquired Resistance in Lung Cancer Patient Forum, and the Immunotherapy for the Treatment of Melanoma, Lung, and Kidney Cancers. I attended two of them and I can tell you that they were amazing. They gave the attendees face-to-face access to experts and the knowledge that real work is being done to help us survive our respective diseases.

GRACE 2014 events Clockwise from left: Patients at the ALK+ Forum, ROS1 patients at the Acquired Resistance Forum, Dr. Taofeek Owonikoko filming a video for GRACE

GRACE produced and posted over 120 videos on its website in 2014. The topics covered head and neck cancer, kidney cancer, lung cancer and melanoma. On top of that, they posted over 50 updates on the news blogs and fielded 700 questions and inquiries in the online forums.

GRACE intends to hold four more forums in 2015, and to continue educating patients not just in lung cancer, but in a growing number of other cancers where exciting changes are coming.

All of these efforts cost money. I think we’ll only continue to see bigger and better things from GRACE in 2015, but they could surely use your help. Please help GRACE with a generous donation today. By learning as much as we can as patients, we are able to become true participants in our own care. GRACE makes that possible.

Donate hand

 

[powerpress image="http://cancergrace.org/lung/files/2014/11/LCAM-Nov-2014-Linnea-Duff-App…"]

 

Next Previous link

Previous PostNext Post

Related Content

Article
The journey to conquer lung cancer is paved with scientific discovery, and the identification of the EGFR and ALK genes as crucial players marks a significant milestone. Unraveling how mutations in these seemingly small segments of our DNA can unleash the destructive force of cancer has opened up exciting new therapeutic avenues. This exploration delves into the cutting-edge world of EGFR and ALK-targeted therapies, highlighting the progress made and the ongoing quest for even more effective and personalized strategies to combat this formidable disease.
Image
Rare cancers
Video
In these videos,  Dr. Jared Weiss gives a brief overview of NUT Carcinoma, discusses treatment options and possible future treatment.  To watch the complete playlist, click here.  
Article
Don't let the word "small" deceive you. Small cell lung cancer (SCLC) casts a long shadow, impacting lives with its aggressive nature and the complexities of its treatment. But while the challenges are real, so is the progress. Breakthroughs in small cell lung cancer treatment offer hope. Immunotherapy plus chemo-radiation improves survival by 22 months. Screening catches it early.

Forum Discussions

Can SCLC also be treated with targeted therapy?

Hi amitchouhan,

Welcome to Grace. At this time, there aren't any targeted therapies to treat SCLC, but there are new treatments. Check out our latest OncTalk webinar from December. The last...

I was searching for this, Thank you so much for the info.

Recent Comments

JOIN THE CONVERSATION
Yes, it's crucial to discuss…
By JanineT GRACE … on
Definitely a good idea to…
By OakleeFarnick on
Thank you for sharing
By LeviDrake on
Hi bluesun,I don't know of…
By JanineT GRACE … on